Original Research |
| |
Efficacy and Safety of Etanercept in Patients with Ankylosing Spondylitis
Gökhan Kalı*, Yüksel Ersoy**, Bekir Durmuş**, Zuhal Altay**, Özlem Baysal**, Yasemin Ersoy . Abstract | | | |
Objective: The aim of this study was to evaluate efficacy and safety of etanercept in patients with ankylosing spondylitis (AS).
Material and Methods: 21 patients with AS were evaluated before and after 6 months of etanercept treatment based on the clinical and laboratory parameters. Clinical efficacy was determined using criteria defined by the asessment in AS (ASAS) International Working Group (ASAS-20 ASAS-40, ASAS-5/6, and ASAS partial remission) and BASDAI-50 responses.
Results: There were statistically significant improvements in all clinical and laboratory parameters after the six months of etanercept treatment (p
|
|
|
|